ERBB2 and breast carcinoma: A recent study analyzed microarray data of breast cancer expression profiling and demonstrated a significant (1.5 fold) increase in the expression of the ATP1A1gene (coding the α1-subunit of NKP) in tissues obtained from different breast cancer patient groups (triple negative, Her2-positive, and Luminal A and B) compared to normal breast tissues [20].